Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Vastesaeger, Nathan, Kutzbach, Abraham Garcia, Amital, Howard, Pavelka, Karel, Alicia Lazaro, Maria, Moots, Robert J ORCID: 0000-0001-7019-6211, Wollenhaupt, Juergen, Zerbini, Cristiano AF, Louw, Ingrid, Combe, Bernard
et al (show 8 more authors) (2016) Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab. RHEUMATOLOGY, 55 (8). 1466 - 1476.


Durez, Patrick, Pavelka, Karel, Alicia Lazaro, Maria, Garcia-Kutzbach, Abraham, Moots, Robert J ORCID: 0000-0001-7019-6211, Amital, Howard, Govoni, Marinella and Vastesaeger, Nathan
(2018) Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. CLINICAL RHEUMATOLOGY, 37 (5). 1417 - 1420.


Moots, Robert J ORCID: 0000-0001-7019-6211, Xavier, Ricardo M, Mok, Chi Chiu, Rahman, Mahboob U, Tsai, Wen-Chan, Al-Maini, Mustafa H, Pavelka, Karel, Mahgoub, Ehab, Kotak, Sameer, Korth-Bradley, Joan
et al (show 4 more authors) (2017) The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study (vol 12, e0175207, 2017). PLOS ONE, 12 (6).


Moots, Robert J ORCID: 0000-0001-7019-6211, Xavier, Ricardo M, Mok, Chi Chiu, Rahman, Mahboob U, Tsai, Wen-Chan, Al-Maini, Mustafa H, Pavelka, Karel, Mahgoub, Ehab, Kotak, Sameer, Korth-Bradley, Joan
et al (show 4 more authors) (2017) The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study. PLOS ONE, 12 (4).

This list was generated on Sun Nov 17 14:02:12 2019 GMT.